CureApp

Last updated: June 14, 2024

CEO Kohta Satake
CEO Kohta Satake
Japan | Funding: ¥13.3B (+)

Website: https://cureapp.co.jp/

CureApp is involved in the research and development of prescription and non-prescription digital therapeutics applications. CureApp's prescription DTx app is used for the treatment of hypertension.